Rose Mercadante Seminar Series  

The Department of Chemistry and Biochemistry Rose Mercadante Seminar Series is pleased to present a seminar entitled:

Peroxisome Targeted Protein Biologics: A New Therapeutic Drug Class?

by Dr. Stanley Terlecky of the Seton Hall Hackensack Meridian School of Medicine. 

The seminar will be held on Tuesday September 20, 2016 at 5:45 p.m. in the Helen Lerner Amphitheater in the Science and Technology Center. Refreshments are available at 5:30.

Peroxisomes are vital subcellular organelles of human cells. Their crucial role in a number of fundamental physiological processes makes them essential for human health. Errors in organelle formation or function are associated with devastating disease. Unfortunately, many children worldwide suffer from such pathologies, with few therapeutic options available. In recent years, the molecular mechanisms of peroxisome biogenesis have become reasonably well understood. The goal now is to harness such knowledge and design strategies to treat, or prevent, human peroxisome disease. The seminar, "Peroxisome Targeted Protein Biologics: A New Therapeutic Drug Class?", will explore one such potential approach.

Dr. Stanley R. Terlecky is a graduate of New York University with a degree in Fine Arts. After graduate work at Harvard University, he earned his Ph.D. in Cellular and Molecular Physiology at Tufts University. An NIH-sponsored fellowship at the University of California followed, after which Dr. Terlecky joined the Pharmacology faculty at the Wayne State University School of Medicine. An author of some 50 published articles and several US and international patents, he is currently an Associate Dean at the nascent Seton Hall–Hackensack–Meridian School of Medicine.